Dr. Hatoon Ezzat received her medical degree in 1995, and pursued specialist training in internal medicine and hematology. She obtained certification in internal medicine and hematology from the American Board of Internal Medicine (ABIM) and is a fellow of the Royal College of Physicians and Surgeons of Canada. She plays an active role in clinical research, and her major medical interests are hemoglobinopathies, including thalassemia and sickle-cell anemia.

Dr. Hatoon Ezzat had obtained Master of Science in Hemoglonbinopathy from University College London in England and currently is the director of the Provincial Adult Hemoglobinopathy Program of British Columbia and the director of the Provincial Home Hemosiderosis (Iron Chelation) Program of British Columbia. She is associated with University of British Columbia as a Clinical Assistant Professor. Dr. Hatoon Ezzat plays an active role in clinical research. She had published in the field of Lymphoma and HIV and her most recent work is on liver iron overload and iron chelation therapy.

Representative Publications:

Utility of Transient Elastography in Estimating Hepatic Iron Concentration in Comparison to Magnetic Resonance Imaging in Patients Who are Transfusion-Dependent: A Canadian Center Experience

Improved survival in HIV-associated diffuse large B-cell lymphoma with the addition of rituximab to chemotherapy in patients receiving highly active antiretroviral therapy

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy

HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era

Share

Discuss in Social Wall

Twitter

Share to SCDteam

+myBinder